Brain Biomarker Market Trends 2025 and Competitor Growth Analysis Report By Technology (Neuroimaging, Genetic Testing, Proteomic Analysis, Metabolomic Profiling, Polymerase Chain Reaction), By Application (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Traumatic Brain Injury, Epilepsy), By End Use (Diagnostic Laboratories, Research Institutions, Hospitals, Pharmaceutical Companies), By Biomarker Type (Genetic Biomarkers, Proteins Biomarkers, Metabolites Biomarkers, Imaging Biomarkers) and By Regional, Share, Industry Size, Developments and Forecast to 2035The Brain Biomarker Market is currently experiencing a period of robust market growth, underpinned by critical advancements in diagnostic and therapeutic strategies for neurological conditions. According to recent Market Data, the Market Size of the Brain Biomarker Market stood at $8.72 billion in 2024 and is projected to reach $9.46 billion in 2025. This momentum is expected to continue strongly over the next decade, with the Market forecast projecting a total Market Size of $21.4 billion by 2035, demonstrating a compelling Compound Annual Growth Rate (CAGR) of 8.5% across the forecast period of 2025 to 2035. This sustained expansion is a direct result of increasing Market Demands for earlier and more accurate diagnosis of complex brain disorders, making the market a focal point for Market Business Insights.